glp 1 gila monster Curious how a slow-moving lizard sparked one of the biggest pharmaceutical breakthroughs of our time? The blockbuster GLP-1 drugs behind today's diabetes and weight-loss treatments have an origin story few people know Why Useless Knowledge Can Be

Vazirnia is a dermatologist who did a study in conjunction with the very famous lipedema Dr

Amycretin is a single peptide engineered to activate both receptors simultaneously and has demonstrated up to 24% weight loss in Phase 2 trials, essentially on par with current medications

doi: 10.1007/s00281-019-00741-8 199 ReinckeSMvon WardenburgNHomeyerMAKornauHCSpagniGLiLYet al

This economic design obviates tedious dialysis and buffer exchange steps

found that TMAO promoted the release of pro-inflammatory cytokines such as IL-1 and TNF- to stimulate the cardiac autonomic nervous system (CANS) and worsen ischemia-induced VA (127)